The chairman and former Chief Executive Officer of the Reuters news agency - James C. Smith - is a top investor and board member for pharmaceuticals giant Pfizer.
He was elected to the board in 2014, as well as joining Pfizer's Corporate Governance and Science and Technology Committees.
The news raises serious conflict of interest concerns as corporate media outlets such as Reuters continue to promote Pfizer products, defend pharmaceuticals companies from criticism, and move to silence skeptics.
In an official statement at the time, Ian Read, Pfizer's chairman and CEO said: "We are pleased to have Jim Smith join Pfizer's Board of Directors. He brings leadership and operational and international business experience to Pfizer's Board, and will be an excellent asset to the company. The addition of Jim to our Board helps ensure that Pfizer will continue to benefit from a breadth and variety of experience."
In the last year alone, Reuters has published more than 22,000 articles mentioning Pfizer.
Many of the articles about Johnson & Johnson were negative in sentiment, unlike their Pfizer reporting.
Smith is also linked to the World Economic Forum, where he serves on the board of Partnering Against Corruption Initiative.
https://thenationalpulse.com/news/conflict-reuters-chairman-is-pfizer-investor-and-board-member/
No comments:
Post a Comment